CNBC November 6, 2025
Key Points
– President Donald Trump announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming pills, in a landmark effort to expand access to the costly blockbuster treatments.
– The agreements will lower prices of GLP-1 drugs on Medicare and Medicaid and offer the treatments directly to consumers at a discount on a website the Trump administration is launching in January 2026 called TrumpRx.gov.
– The deals are among the most politically significant announcements to date in the Trump administration’s efforts to rein in high U.S. drug costs by tying them to the lowest prices abroad.
President Donald Trump on Thursday announced deals with Eli Lilly and Novo...
Today's Sponsors
Today's Sponsor